Keyphrases
AIDS/HIV
100%
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
Zidovudine
100%
Antiretroviral Agents
100%
Resistance Development
100%
University of Minnesota
50%
Virus
50%
Therapeutic Agents
50%
Rapid Development
50%
Care Provision
50%
Human Immunodeficiency Virus Infection
50%
Nucleoside Reverse Transcriptase Inhibitors
50%
Loss-of-susceptibility
50%
Erice
50%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
50%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus 1
100%
Antiretrovirus Agent
100%
Zidovudine
100%
Human Immunodeficiency Virus Infection
50%
Virus
50%
Deterioration
50%
Reverse-Transcriptase Inhibitor
50%
Therapeutic Agent
50%
Nonnucleoside Reverse Transcriptase Inhibitor
50%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Zidovudine
100%
Human Immunodeficiency Virus 1
100%
Antiretrovirus Agent
100%
Human Immunodeficiency Virus Infection
50%
RNA Directed DNA Polymerase Inhibitor
50%
Deterioration
50%
Nonnucleoside Reverse Transcriptase Inhibitor
50%
Nursing and Health Professions
Human Immunodeficiency Virus
100%
Antiretrovirus Agent
100%
Virus Typing
100%
Zidovudine
66%
RNA Directed DNA Polymerase Inhibitor
33%
Human Immunodeficiency Virus Infection
33%
Deterioration
33%
Nonnucleoside Reverse Transcriptase Inhibitor
33%